Medication Adherence in Patients with Schizophrenia Using the Medication Adherence Rating Scale (MARS) for Psychosis in Urban Communities

Ruliyani Manumba, Gusti Agung Ayu Putri Ariani, Mansyur Babuta Tomayahu

Abstract


Medication non-adherence is one of the major challenges among patients with schizophrenia. Non-adherent behavior increases the risk of relapse and hospital readmission. Medication adherence in patients with schizophrenia is influenced by various factors, which may be affected by the patient's living environment, including the characteristics of urban communities. This study aimed to describe medication adherence among patients with schizophrenia living in urban community settings. This study employed a quantitative descriptive design. The study population consisted of patients with schizophrenia residing within the service areas of community health centers in Gorontalo City. A proportionate stratified sampling technique based on community health center service areas was used to select a sample of 138 respondents. The research instruments included a demographic characteristics questionnaire and the Medication Adherence Rating Scale (MARS) for psychosis to assess medication adherence. Of the total respondents, 62.3% demonstrated low medication adherence, while 37.7% demonstrated high adherence. Demographic characteristics indicated that the majority of respondents were male (64.7%), with the largest age group being 18–39 years (57.2%). Most respondents had completed senior high school education (73.9%), were unemployed (69.9%), had household incomes below the regional minimum wage (57.2%), were prescribed atypical antipsychotic medications (63.0%), and more than half of the respondents (59.4%) were smokers.The findings indicate that medication adherence among patients with schizophrenia living in urban areas remains low. Healthcare professionals are encouraged to strengthen patient and family education, provide counseling, and conduct regular monitoring of medication adherence to improve treatment outcomes and enhance therapeutic success

Keywords


Medication adherence; Urban community; Medication Adherence Rating Scale (MARS) for Psychosis; Schizophrenia

Full Text:

PDF

References


Chandra, I. S., Kumar, K. L., Reddy, M. P., Muni, C., & Kumar, P. (2014). Original Article Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia. 36(3). https://doi.org/10.4103/0253-7176.135383

Desai, R., & Nayak, R. (2019). Effects of Medication Nonadherence and Comorbidity on Health Resource Utilization in Schizophrenia. 25(1).

Efendi, S., Keliat, B. A., & Mustikasari. (2020). Pengaruh Tindakan Keperawatan Ners, Cognitive Behaviour Therapy dan Psikoedukasi Keluarga terhadap Pencegahan Faktor Risiko Kekambuhan Klien Perilaku Kekerasan dan Halusinasi di Rumah Sakit Jiwa. Universitas Indonesia.

Ghosh, P., Balasundaram, S., Sankaran, A., Chandrasekaran, V., Sarkar, S., & Choudhury, S. (2022). Factors associated with medication non-adherence among patients with severe mental disorder - A cross sectional study in a tertiary care centre. Exploratory Research in Clinical and Social Pharmacy, 7(August), 100178. https://doi.org/10.1016/j.rcsop.2022.100178

Gibson, S., Brand, S. L., Burt, S., Boden, Z. V. R., & Benson, O. (2013). Understanding treatment non-adherence in schizophrenia and bipolar disorder : a survey of what service users do and why.

Higashi, K., Medic, G., Littlewood, K. J., Diez, T., Granström, O., & Hert, M. De. (2013). Medication adherence in schizophrenia : factors influencing adherence and consequences of nonadherence , a systematic literature review. https://doi.org/10.1177/2045125312474019

Issac, A., Nayak, S. G., George, R., Priyadarshini, T., & Jacob, J. (2025). Barriers and Facilitators to Medication Adherence Among Individuals With Mental Disorders: A Qualitative Systematic Review and Evidence Synthesis. Nursing & Health Science, 27(2). https://doi.org/https://doi.org/10.1111/nhs.70153

Jauhar, S., Johnstone, M., & McKenna, P. J. (2022). Schizophrenia. The Lancet, 399(10323), 473–486.

Karabulut, B., & Uslu, E. (2024). Schizophrenia and medication adherence: Associated factors. Archives of Psychiatric Nursing, 49, 47–54. https://doi.org/https://doi.org/10.1016/j.apnu.2024.01.015.

Kondrátová, L., König, D., Mladá, K., & Winkler, P. (2019). Correlates of Negative Attitudes towards Medication in People with Schizophrenia. Psychiatric Quarterly, Volume 90, pages 159–169.

Li, X.-H., Deng, S.-Y., Zhang, T.-M., Wang, Y.-Z., Wong, I. Y. L., Ran, & Mao-Sheng. (2024). Medication non-adherence and its influencing factors in persons with schizophrenia in rural China. Journal of Mental Health, 33(1), 40–47. https://doi.org/https://doi.org/10.1080/09638237.2022.2140789

Mi, W., Chen, X., Fan, T., Tabarak, S., Xiao, J., Cao, Y., Li, X., Bao, Y., Han, Y., Li, L., & Shi, Y. (2020). Identifying Modi fi able Risk Factors for Relapse in Patients With Schizophrenia in China. 11(September), 1–11. https://doi.org/10.3389/fpsyt.2020.574763

Moritz, S., Hünsche, A., & Lincoln, T. M. (2014). Nonadherence to antipsychotics: The role of positive attitudes towards positive symptoms. European Neuropsychopharmacology, 24(11), 1745–1752. https://doi.org/https://doi.org/10.1016/j.euroneuro.2014.09.008

Nomura, N., Siafis, S., Schneider-thoma, J., Brandt, L., Park, J., Efthimiou, O., Priller, J., & Davis, J. M. (2025). The trajectory of sedative adverse events caused by antipsychotics : a meta-analysis of individual participant data from randomised , placebo-controlled , clinical trials in acute phase schizophrenia. The Lancet Psychiatry, 12(4), 266–275. https://doi.org/10.1016/S2215-0366(25)00025-2

Rahayu, N. W. (2014). Pengaruh Terapi Psikoedukasi Keluarga terhadap Dukungan Keluarga dan Kepatuhan Minum Obat pada Anggota Keluarga dengan Skizofrenia di Wilayah Puskesmas Kalasan Yogyakarta. Universitas INdonesia.

Sitawati, L., Wuryaningsih, C. E., Anshari, D., & Departement, H. P. (2019). Akses Pelayanan Rumah Sakit Menjadi Faktor Dominan Kepatuhan Minum Obat pada Penderita Skizofrenia. Jurnal Kesehatan,Sai MetroSai Metro, 12(1), 1–10.

Smith, F., & Clifford, S. (2011). Adherence to medication among chronic patients in Middle Eastern countries : review of studies. Eastern Mediterranean Health Journal, 17(4).

Stentzel, U., Berg, N. Van Den, Schulze, L. N., Schwaneberg, T., Radicke, F., Langosch, J. M., Freyberger, H. J., Hoffmann, W., & Grabe, H. (2018). Predictors of medication adherence among patients with severe psychiatric disorders : findings from the baseline assessment of a randomized controlled trial ( Tecla ). 1–8.

Stürup, A. E., Hjorthøj, C., Jensen, H. D., Melau, M., Davy, J. W., Nordentoft, M., & Albert, N. (2023). Early Intervention Psych - 2023 - Stürup - Self‐reported reasons for discontinuation or continuation of antipsychotic.pdf. Early Intervention in Psychiatry, 17(10), Pages 945-1041. https://doi.org/https://doi.org/10.1111/eip.13389o

Suzuki, T., Uchida, H., Takeuchi, H., Tsuboi, T., Hirano, J., & Mimura, M. (2014). A review on schizophrenia and relapse—a quest for user-friendly psychopharmacotherapy. Human Psychopharmacology: Clinical and Experimental, 29(5), 414–426. https://doi.org/https://doi.org/10.1002/hup.2421

Tareke, M., Tesfaye, S., Amare, D., Belete, T., & Abate, A. (2018). Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia. South African Journal of Psychiatry, 24.

Tham, X. C., Xie, H., Chng, C. M. L., Seah, X. Y., Lopez, V., & Klainin-Yobas, P. (2016). Factors Affecting Medication Adherence Among Adults with Schizophrenia: A Literature Review. Archives of Psychiatric Nursing, 30(6), 797–809.

Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & John, P. (2017). Why do psychiatric patients stop antipsychotic medication ? A systematic review of reasons for nonadherence to medication in patients with serious mental illness Why do psychiatric patients stop antipsychotic medication ? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. https://doi.org/10.2147/PPA.S124658

Warriach, Z. I., Sanchez-gonzalez, M. A., & Ferrer, G. F. (2021). Suicidal Behavior and Medication Adherence in Schizophrenic Patients. 13(1), 1–6. https://doi.org/10.7759/cureus.1247




DOI: https://doi.org/10.37311/jnj.v8i2.40023

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Ruliyani Manumba, Gusti Agung Ayu Putri Ariani, Mansyur Babuta Tomayahu

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.